Stocks are continuing to pause, which is constructive. One area of potential concern could be the small caps, which posted an outsized decline even though the 10-year yield continued to back off. Axon stock broke out on earnings, while Eli Lilly jumped on drug approval news. Dell is continuing to hold in a buy range with a bullish relative strength line.
Stocks are continuing to pause, which is constructive. One area of potential concern could be the small caps, which posted an outsized decline even though the 10-year yield continued to back off. Axon stock broke out on earnings, while Eli Lilly jumped on drug approval news. Dell is continuing to hold in a buy range with a bullish relative strength line.